TR199901754T2 - Helicobacter pylori enfeksiyonlarinin ve bunlarla baglantili gastro-duodenal rahatsizliklarin tedavisinde - Google Patents

Helicobacter pylori enfeksiyonlarinin ve bunlarla baglantili gastro-duodenal rahatsizliklarin tedavisinde

Info

Publication number
TR199901754T2
TR199901754T2 TR1999/01754T TR9901754T TR199901754T2 TR 199901754 T2 TR199901754 T2 TR 199901754T2 TR 1999/01754 T TR1999/01754 T TR 1999/01754T TR 9901754 T TR9901754 T TR 9901754T TR 199901754 T2 TR199901754 T2 TR 199901754T2
Authority
TR
Turkey
Prior art keywords
treatment
helicobacter pylori
pylori infections
related gastro
duodenal disorders
Prior art date
Application number
TR1999/01754T
Other languages
English (en)
Inventor
Matzke Michael
Petersen Uwe
Jaetsch Thomas
Bartel Stephan
Schenke Thomas
Himmler Thomas
Baasner Bernd
Werling Hans-Otto
Schaller Klaus
Labischinski Harald
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of TR199901754T2 publication Critical patent/TR199901754T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Bu bulus 7-pozisyonunda 2-oksa-5,8-diazabisiklo[4.3.0]non-8-il kökü ile yer degistiren kinolon- ve naftiridonkarboksilik asit türevleri ve tuzlarinin Helicobacter pylori enfeksiyonlarinin bunlarla baglantili gastro-duodenal rahatsizliklarin tedavisinde kullanimina ilskindir.
TR1999/01754T 1996-12-16 1997-12-04 Helicobacter pylori enfeksiyonlarinin ve bunlarla baglantili gastro-duodenal rahatsizliklarin tedavisinde TR199901754T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19652239A DE19652239A1 (de) 1996-12-16 1996-12-16 Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen

Publications (1)

Publication Number Publication Date
TR199901754T2 true TR199901754T2 (tr) 1999-09-21

Family

ID=7814837

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/01754T TR199901754T2 (tr) 1996-12-16 1997-12-04 Helicobacter pylori enfeksiyonlarinin ve bunlarla baglantili gastro-duodenal rahatsizliklarin tedavisinde

Country Status (27)

Country Link
US (2) US6133260A (tr)
EP (1) EP0946176B1 (tr)
JP (3) JP3463939B2 (tr)
KR (1) KR100536153B1 (tr)
CN (1) CN100335054C (tr)
AT (1) ATE214929T1 (tr)
AU (1) AU717751B2 (tr)
BG (1) BG64615B1 (tr)
BR (1) BR9714032A (tr)
CA (1) CA2274894C (tr)
CZ (2) CZ297363B6 (tr)
DE (2) DE19652239A1 (tr)
DK (1) DK0946176T3 (tr)
EA (1) EA002477B1 (tr)
EE (1) EE04090B1 (tr)
ES (1) ES2175519T3 (tr)
HU (1) HU226523B1 (tr)
IL (1) IL130311A (tr)
NO (1) NO325617B1 (tr)
NZ (2) NZ336228A (tr)
PL (1) PL191193B1 (tr)
PT (1) PT946176E (tr)
RS (1) RS49684B (tr)
SK (2) SK283224B6 (tr)
TR (1) TR199901754T2 (tr)
UA (1) UA57055C2 (tr)
WO (1) WO1998026779A1 (tr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19633805A1 (de) * 1996-02-23 1997-08-28 Bayer Ag Gegenenenfalls substituierte 8-Cyan-l-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre Derivate
ATE245140T1 (de) * 1998-11-18 2003-08-15 Asahi Glass Co Ltd Derivate der aminoacryl-säure und ein verfahren zur herstellung derselben
DE19917617A1 (de) * 1999-04-19 2000-10-26 Bayer Ag -(-)Enantiomeres des 2-[2-(1-Chlor-cyclopropyl)-3-(2-chlorphenyl) 2-hydroxy-propyl]-2,4-dihydro-[1,2,4]-triazol-3-thions
IL147043A0 (en) * 1999-07-01 2002-08-14 Wakunaga Pharma Co Ltd Quinolinecarboxylic acid derivative or salts thereof
ATE285821T1 (de) * 1999-10-08 2005-01-15 Affinium Pharm Inc Fab i inhibitoren
CA2444597A1 (en) * 2001-04-06 2002-10-06 Affinium Pharmaceuticals, Inc. Fab i inhibitors
EP1575951B1 (en) 2002-12-06 2014-06-25 Debiopharm International SA Heterocyclic compounds, methods of making them and their use in therapy
DE602004016831D1 (de) 2003-03-17 2008-11-13 Affinium Pharm Inc Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend
EP1669354B1 (en) 2003-09-29 2013-03-20 Daiichi Sankyo Company, Limited 8-cyanoquinolonecarboxylic acid derivative
CN1244582C (zh) * 2004-04-21 2006-03-08 中国医学科学院医药生物技术研究所 喹诺酮羧酸类化合物及其制备方法和医药用途
US7759362B2 (en) 2004-04-21 2010-07-20 Institut Of Medicinal Biotechnology Chinese Academy Of Medical Sciences Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof
EP2848614A3 (en) 2004-06-04 2015-07-29 Debiopharm International SA Acrylamide derivatives as antibiotic agents
EP1973902A2 (en) * 2005-12-05 2008-10-01 Affinium Pharmaceuticals, Inc. 3-heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
EP2687533B1 (en) 2006-07-20 2017-07-19 Debiopharm International SA Acrylamide derivatives as FAB I inhibitors
WO2008098374A1 (en) 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
WO2011003091A1 (en) 2009-07-02 2011-01-06 Alcon Research, Ltd. Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections
RU2449805C1 (ru) 2011-01-27 2012-05-10 Общество С Ограниченной Ответственностью "Гармония" Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования
SI2861608T1 (sl) 2012-06-19 2019-08-30 Debiopharm International Sa Derivati predzdravila (E)-N-metil-N-((3-metilbenzofuran-2-IL)metil)- 3-(7-okso-5,6,7,8-tetrahidro-1 ,8-nafthiridin-3-il)akrilamid
US9504691B2 (en) * 2012-12-06 2016-11-29 Alcon Research, Ltd. Finafloxacin suspension compositions
CA2916535A1 (en) 2013-08-12 2015-02-19 Novartis Ag Method for treating otic infections after tympanostomy tube placement
DE102014115951A1 (de) * 2014-11-03 2016-05-04 Merlion Pharmaceuticals Pte Ltd. Zusammensetzungen, die Finafloxacin und Tris enthalten
DE102015100068A1 (de) 2015-01-06 2016-07-07 Merlion Pharmaceuticals Pte Ltd. Finafloxacin zur verwendung bei der behandlung von harnwegsinfektionen
BR122023021456A2 (pt) 2016-02-26 2024-02-20 Debiopharm International S.A. Uso de di-hidrogeno fosfato de {6- [(e)-3-{metil[(3-metil-1-benfofuran-2- iol)metil]amino)-3- oxopro-1-en-1-il]-2-oxo-3,4-di-hidro-1,8-naftiridin-1(2h)- il}metila para tratamento de osteomielite do pé diabético e composição farmacêutica
CN107987074B (zh) * 2017-10-27 2020-12-29 浙江美诺华药物化学有限公司 一种普拉沙星的合成方法
CA3098060A1 (en) * 2018-04-25 2019-10-31 Bayer Animal Health Gmbh Process for the hydrolysis of quinolone carboxylic esters
LT3923914T (lt) 2019-02-14 2023-07-25 Debiopharm International S.A. Afabicino kompozicija, jos gamybos būdas
CN113939306B (zh) 2019-06-14 2024-07-19 德彪药业国际股份公司 用于治疗涉及生物膜的细菌感染的药物及其用途

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4822801A (en) * 1984-07-20 1989-04-18 Warner-Lambert Company 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents
JPS62205060A (ja) * 1986-03-04 1987-09-09 Kyorin Pharmaceut Co Ltd ８位置換キノロンカルボン酸誘導体
DE3702393A1 (de) * 1987-01-28 1988-08-11 Bayer Ag 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo- 3-chinolincarbonsaeuren, verfahren zu ihrer herstellung und diese enthaltende antibakterielle mittel
US5563138A (en) * 1987-04-16 1996-10-08 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
US4889857A (en) * 1987-10-12 1989-12-26 Yoshitomi Pharmaceutical Industries, Ltd. Quinolonecarboxylic acid compounds and pharmaceutical use thereof
WO1989005643A1 (en) * 1987-12-18 1989-06-29 Pfizer Inc. Heterocyclic-substituted quinoline-carboxylic acids
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
US5147873A (en) * 1988-08-23 1992-09-15 Pfizer Inc. Amino-substituted bridged azabicyclic quinolone carboxylic acids and esters
CA2001203C (en) * 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Novel antimicrobial dithiocarbamoyl quinolones
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
US5407932A (en) * 1989-03-31 1995-04-18 Wakunaga Seiyaku Kabushiki Kaisha Quinolone derivatives and antibacterial agents containing the same
US5140033A (en) * 1989-04-03 1992-08-18 Bayer Aktiengesellschaft Antibacterial 5-alkylquinolonecarboxylic acids
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
US5252734A (en) * 1989-04-03 1993-10-12 Bayer Aktiengesellschaft Antibacterial 5-alkylquinolonecarboxylic acids
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
KR910009330B1 (ko) * 1989-10-23 1991-11-11 재단법인 한국화학연구소 항균작용을 갖는 퀴놀린계 화합물과 그의 제조방법
TW209865B (tr) * 1992-01-10 1993-07-21 Bayer Ag
DE4200415A1 (de) 1992-01-10 1993-07-15 Bayer Ag Enantiomerenreine 2-oxa-5,8-diazabicyclo(4.3.0)nonane sowie verfahren zu ihrer herstellung
NO301165B1 (no) * 1992-12-25 1997-09-22 Daiichi Seiyaku Co Bicykliske aminderivater og antibakterielle midler inneholdende disse
DE4309964A1 (de) 1993-03-26 1994-09-29 Bayer Ag Verfahren zur Herstellung enantiomerenreiner trans-2-Oxa-5,8-diazabicyclo[4.3.0]nonane
WO1994025464A1 (en) * 1993-04-24 1994-11-10 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and process for preparing the same
US5532239A (en) * 1993-08-02 1996-07-02 Assistance Publique - Hopitaux De Paris Therapeutic application of fluoroquinolone derivatives
DE4329600A1 (de) * 1993-09-02 1995-03-09 Bayer Ag Pyrido [1,2,3-d,e] [1,3,4] benzoxadiazinderivate
DE69504392T2 (de) * 1994-04-07 1999-02-11 Pfizer Inc., New York, N.Y. Verwendung von Trovafloxacin oder dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung von H.Pylori Infektionen
GB2289674A (en) * 1994-05-23 1995-11-29 Pfizer Antibacterial naphthyridine
JPH0848629A (ja) * 1994-08-08 1996-02-20 Dainippon Pharmaceut Co Ltd ピリドンカルボン酸誘導体およびそれを有効成分とする抗ピロリ菌剤

Also Published As

Publication number Publication date
AU717751B2 (en) 2000-03-30
IL130311A (en) 2004-01-04
JP4463380B2 (ja) 2010-05-19
CZ297363B6 (cs) 2006-11-15
WO1998026779A1 (de) 1998-06-25
EE04090B1 (et) 2003-08-15
HUP0000450A2 (hu) 2000-10-28
PL333928A1 (en) 2000-01-31
KR100536153B1 (ko) 2005-12-14
JP5112395B2 (ja) 2013-01-09
DE19652239A1 (de) 1998-06-18
CA2274894C (en) 2009-04-07
PT946176E (pt) 2002-08-30
CA2274894A1 (en) 1998-06-25
HU226523B1 (en) 2009-03-30
US6133260A (en) 2000-10-17
CZ216899A3 (cs) 2000-02-16
CN100335054C (zh) 2007-09-05
ATE214929T1 (de) 2002-04-15
SK79599A3 (en) 2001-01-18
CZ297364B6 (cs) 2006-11-15
DK0946176T3 (da) 2002-06-10
US6432948B1 (en) 2002-08-13
EA002477B1 (ru) 2002-06-27
AU5854198A (en) 1998-07-15
SK283224B6 (sk) 2003-03-04
EP0946176A1 (de) 1999-10-06
NO992903L (no) 1999-06-14
JP2009235106A (ja) 2009-10-15
NZ506162A (en) 2001-06-29
BR9714032A (pt) 2000-05-09
NO325617B1 (no) 2008-06-30
JP2000351781A (ja) 2000-12-19
JP2000514825A (ja) 2000-11-07
IL130311A0 (en) 2000-06-01
KR20000069483A (ko) 2000-11-25
BG103474A (en) 2000-01-31
SK283223B6 (sk) 2003-03-04
RS49684B (sr) 2007-11-15
NO992903D0 (no) 1999-06-14
JP3463939B2 (ja) 2003-11-05
YU27499A (sh) 2002-10-18
EP0946176B1 (de) 2002-03-27
DE59706808D1 (de) 2002-05-02
CN1245428A (zh) 2000-02-23
UA57055C2 (uk) 2003-06-16
BG64615B1 (bg) 2005-09-30
HUP0000450A3 (en) 2001-02-28
PL191193B1 (pl) 2006-03-31
HK1025517A1 (zh) 2000-11-17
EE9900248A (et) 1999-12-15
SK14962000A3 (sk) 2003-01-09
NZ336228A (en) 2000-12-22
ES2175519T3 (es) 2002-11-16
EA199900526A1 (ru) 2000-08-28

Similar Documents

Publication Publication Date Title
TR199901754T2 (tr) Helicobacter pylori enfeksiyonlarinin ve bunlarla baglantili gastro-duodenal rahatsizliklarin tedavisinde
DE68917163D1 (de) Antibakterielle Mittel.
DE10199018I2 (de) Thiazolidindion-Derivate, deren Herstellung und Anwendung.
IT8847582A0 (it) Composizione orale antibatterica, antiplacca ed antitartaro
NO874393D0 (no) Fremgangsmaate for nedsetting av paaler i grunnen, samt apparat for utfoerelse av fremgangsmaaten.
DE3587974D1 (de) Orale hygienische Zusammenstellungen und ihrer aktiven Polymere.
EP0276543A3 (en) Use of buspirone for the improvement of short term memory
TR200002248T2 (tr) Yeni dihidroksiheksanoik asit türevleri
ES8800160A1 (es) Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
ES2140489T3 (es) Receptor de interferona soluble, su preparacion y su uso.
DK201590A (da) Antihypertensiv hyperimmun maelk, fremstilling, sammensaetning og anvendelse
ES2177625T3 (es) Citoquina cc-1 humana circulante.
AU553269B2 (en) 2,3-diaryl-5-halo thiophenes
NO864718D0 (no) Kosmetisk preparat.
DE3788325D1 (de) Tetrachlorperylen-3,4,9,10-tetracarbonsäurediimidpigment und dessen Verwendung.
ES2194104T3 (es) Uso de selegilina para el tratamiento de la perdida de audicion en mamiferos.
ATE42462T1 (de) Licht- und sonnenschutzmittel.
IT1229223B (it) Composizioni veterinarie sinergisticamente attive e procedimento per la loro preparazione.
TR23146A (tr) Benzohidroksamik asit tuerevleri bunlarin herbisid olarak kullanimi ve bunlari ihtiva eden tarimsal bilesimler
FI851365L (fi) Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
ITMI912466A1 (it) Uso di 1, 2 dipalmitoil-l-alfa-fosfatidil-n, n-dimetiletanolammina, in composizioni dermatologiche
NO970185L (no) Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi
DE58906997D1 (de) Fungizide und herbizide Mittel sowie substituierte 2-Cyclohexen-1-yl-amin-Derivate und deren Herstellung.
DE3777359D1 (de) Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns.
BR9704964A (pt) Uso de sulbutiamina para obter composições farmacêuticas úteis no tratamento de algumas pertubações psicomotoras e psico-intelectuais